Guangzhou Innogen Pharma schedules board meeting on interim results, dividend reviewPUBT·Aug 13 at 03:38 AM02591-0.71%
01:25 ETInnogen Pharmaceuticals Receives PIC/S GMP Certificatation, Accelerating Global Expansion of Efsubaglutide Alfaprnewswire·Aug 4 at 12:26 AM02591-0.71%
Guangzhou Innogen says ANVISA grants PIC/S GMP certificates for two contract sites for ecnoglutide alpha injectionPUBT·Aug 3 at 06:43 AM02591-0.71%
